COVID-19 Vaccine
At this time, the federal government is giving Maryland approximately 14,000 doses per day for over 2 million people who are eligible. SUPPLY IS VERY LIMITED, especially as the vaccine is becoming available to more people. PLEASE BE PATIENT as the available supply of the vaccine in Maryland works to catch up to the demand. The vaccine will eventually be available to all Marylanders.
Maryland COVID-19 vaccine priority groups
Maryland will distribute the vaccines to five different priority groups based on relative risk of exposure or developing serious illness.
Vaccine prioritization may be subject to change. The state has adopted a rolling vaccine allocation model, meaning it may not wait for every member of a particular group to get vaccinated before moving ahead; individuals will still have the opportunity to be vaccinated in subsequent phases.
WE ARE IN PHASE 1C
Currently Eligible Groups
Phase 1A
Health care workers
Residents and staff of nursing homes
First responders, public safety, corrections
Phase 1B
Individuals with intellectual and developmental disabilities
Assisted living, independent living, behavioral health and developmentally disabled group homes, and other congregate facilities
Adults age 75 and older
Education and continuity of government
Phase 1C
Adults age 65-74
Essential workers in lab services, agriculture, manufacturing, postal service
*Maryland is currently in this stage
Phase 2
Adults 16-64 at increased risk of severe COVID-19 illness due to comorbidities
Essential workers in critical utilities, transportation, food service
Phase 2 will begin after the majority of the Phase 1 has been vaccinated or the federal government’s allocation of vaccines increase.
Phase 3
General population, including healthy adults age 16-64
Phase 3 will begin once the majority of Phase 2 has been vaccinated and/or the federal government’s allocation of vaccines to the state increase.
What are the vaccines?
Pfizer | Vaccine has been authorized for emergency use | Two doses, delivered three weeks apart | 95% effective at preventing serious illness | Injection-site pain, fatigue, headaches, chills |
Moderna | Vaccine has been authorized for emergency use | Two doses, delivered four weeks apart | 94.1% effective at preventing serious illness | Injection-site pain, fatigue, muscle aches, joint pain, headaches, chills |
Johnson & Johnson | Vaccine has been authorized for emergency use | One Dose | 85% effective at preventing severe illness | Injection site pain, fatigue, headache, muscle pain, joint pain |
Novavax | Vaccine trials are ongoing | Two doses, delivered three weeks apart | – | Injection site pain, rash, headaches, muscle pain, fever |
AstraZeneca | Vaccine trials are ongoing | Two doses, delivered four weeks apart | – | Fever, muscle aches, headaches, injection site pain |
No comments:
Post a Comment